Dr. Felix Paulußen

Co-Managing Director 

Felix is a chemical biologist who earned his Ph.D. from VU Amsterdam, Netherlands. After completing his doctorate, he pursued a postdoctoral fellowship in Tom Grossmann’s laboratory, where he focused on peptide inspired β catenin inhibitors. Building on that work, Felix secured an NWO Faculty of Impact fellowship and advanced the valorization of these inhibitors toward colorectal cancer therapy. The fellowship, together with Biotech Booster funding, gave him first hands on experience in the startup field.